Gamida Cell Ltd.

0.32 USD
-0.01 (-2.45%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Gamida Cell Ltd. stock is down -53.91% since 30 days ago. The next earnings date is Mar 25, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 5 December’s closed higher than November. In the last 1 Unusual Options Trades, there were 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
14 Nov 17:48 15 Dec, 2023 3.00 PUT 114 343

About Gamida Cell Ltd.

Gamida Cell Ltd. develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk malignancies, as well as in Phase I/II clinical trials.

  • Needham
    Tue Dec 5, 06:56
  • Piper Sandler
    Wed Nov 15, 10:31
  • HC Wainwright & Co.
    Wed Nov 15, 07:44